Evaluation of clinical complete response to neoadjuvant chemotherapy in primary breast cancer using (18F)-fluorodeoxyglucose positron emission tomography

被引：0
|
作者：
Burcombe, RJ
Makris, A
Pittam, M
Lowe, J
Emett, J
Wong, WL
机构：
[1] Mt Vernon Hosp, Marie Curie Res Wing, Northwood HA6 2RN, Middx, England
[2] Mt Vernon Hosp, Paul Strickland Scanner Ctr, Northwood HA6 2RN, Middx, England
来源：
BRITISH JOURNAL OF CANCER | 2001年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：50 / 50
页数：1
相关论文
共 50 条
  • [31] Utility of [18F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) in the initial staging and response assessment of locally advanced breast cancer patients receiving neoadjuvant chemotherapy
    Hulikal N.
    Gajjala S.R.
    Kalawat T.C.
    Kottu R.
    Yadagiri L.A.
    Indian Journal of Surgical Oncology, 2015, 6 (4) : 330 - 336
  • [32] Complete Metabolic Response on Interim 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography to Predict Long-Term Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy
    Chen, Suyun
    Ibrahim, Nuhad K.
    Yan, Yuanqing
    Wong, Stephen T.
    Wang, Hui
    Wong, Franklin C.
    ONCOLOGIST, 2017, 22 (05): : 526 - 534
  • [33] [18F] Fluorodeoxyglucose positron emission (FDG-PET) in breast cancer: Clinical utility in neoadjuvant and metastatic setting.
    Morales Murillo, Serafin
    Gasol Cudos, Ariadna
    Veas Rodriguez, Joel
    Canosa Morales, Carles
    Mele Olive, Jordi
    Salud, Antonia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [34] The 18F-fluorodeoxyglucose positron emission tomography/computed tomography in breast cancer
    Mihailovic, Jasna
    Ubavic, Milan
    VOJNOSANITETSKI PREGLED, 2017, 74 (06) : 571 - 580
  • [35] [18F]fluorodeoxy-D-glucose positron emission tomography may predict the pathological response of breast cancer to primary chemotherapy
    Gardiner, E
    Ogston, K
    Smith, IC
    Welch, AE
    Sharp, P
    Hutcheon, AW
    Ah-See, AK
    Eremin, O
    Heys, SD
    BRITISH JOURNAL OF SURGERY, 2001, 88 (05) : 761 - 761
  • [36] Is [18F]fluorodeoxyglucose positron emission tomography the ultimate tool for response and prognosis assessment?
    Brepoels, Lieselot
    Stroobants, Sigrid
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (05) : 855 - +
  • [37] Monitoring Primary Systemic Therapy of Large and Locally Advanced Breast Cancer by Using Sequential Positron Emission Tomography Imaging With [18F] Fluorodeoxyglucose
    Schwarz-Dose, Joerg
    Untch, Michael
    Tiling, Reinhold
    Sassen, Stefanie
    Mahner, Sven
    Kahlert, Steffen
    Harbeck, Nadia
    Lebeau, Annette
    Brenner, Winfried
    Schwaiger, Markus
    Jaenicke, Fritz
    Avril, Norbert
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 535 - 541
  • [38] [18F]-Fluorodeoxyglucose Positron Emission Tomography and Response to Therapy in Idiopathic Retroperitoneal Fibrosis
    Buttini, Eugenia Accorsi
    Maritati, Federica
    Vaglio, Augusto
    EUROPEAN UROLOGY, 2018, 73 (01) : 145 - 146
  • [39] Clinical value of positron emission tomography with [18F]fluorodeoxyglucose in the follow up of colorectal cancer surgery
    Kang, SJ
    Park, SB
    Yun, SH
    Lee, WY
    Chun, HK
    DISEASES OF THE COLON & RECTUM, 2004, 47 (04) : 655 - 655
  • [40] Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix:: Response and outcome
    Grigsby, PW
    Siegel, BA
    Dehdashti, F
    Rader, J
    Zoberi, I
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) : 2167 - 2171
12345